← Leaderboards
Michael R Morissette
Beth Israel Deaconess Medical Center
$606,150
Attributed
$606,150
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $121.2K · FY2006–10$200K$150K$100K$50K$0
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$606,150 · 1
By mechanism
K01$606,150 · 1
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Barbara B Kahn$32,891,170
- Bruce Furie$39,376,853
- Richard A. Hodin$11,784,355
- Albert Mark Galaburda$4,480,643
- Cornelis P Terhorst$22,963,281
Others in their field
Top investigators on “Event”
- Everette D Joseph · Howard University$250,079,293
- Valerie Koch · University Corporation For Atmospheric Res$247,762,266
- Eric J Barron · Pennsylvania State Univ University Park$243,972,016
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- Francis L Halzen · University Of Wisconsin-Madison$229,314,069
Research focus
EventGeneticAdultEvaluationFailure (Biologic Function)Active LearningApoptoticAge RelatedAwardAgingAging PopulationCardiacApoptosisAgedCardiovascular SystemCareerAreaCause Of DeathCessation Of LifeCommitBaseComplementBiology Of AgingGene Transfer
Grant awards (6)
The Role of Myostatin in Cardiac Hypertrophy and Failure$121,230
K01 · FY2010 · AG · contact PI
The Role of Myostatin in Cardiac Hypertrophy and Failure$121,230
K01 · FY2009 · AG · contact PI
The Role of Myostatin in Cardiac Hypertrophy and Failure$77,464
K01 · FY2008 · AG · contact PI
The Role of Myostatin in Cardiac Hypertrophy and Failure$43,766
K01 · FY2008 · AG · contact PI
The Role of Myostatin in Cardiac Hypertrophy and Failure$121,230
K01 · FY2007 · AG · contact PI
The Role of Myostatin in Cardiac Hypertrophy and Failure$121,230
K01 · FY2006 · AG · contact PI